Lung cancer and pleural mesothelioma are often confused, so it’s important to understand the key differences between them, including tumor location and treatments. Lung cancer and pleural mesothelioma ...

In the last few years the health-damaging effects of asbestos have led to an increase in pleural cancers. A new interdisciplinary research laboratory is set to lead to scientific advances in treatment ...

Fibulin-3 (FBLN3) was recently presented as a promising novel biomarker for malignant pleural mesothelioma (MPM), warranting independent validation studies. ELISA was used to measure cellular and ...

Lung is the leading cancer site in males, comprising 17% of the total new cancer cases and 23% of the total cancer deaths. Cancer survival tends to be poorer in developing countries, most likely ...

Background: Pleural cancer is a recognised indicator of exposure to asbestos and mesothelioma mortality. Aims: To investigate the distribution of municipal mortality due to this tumour, using the ...

Ethnic difference in chemoradiation-induced esophagitis in unresectable stage III non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the 2014 ASCO Annual Meeting I. This ...

CALGB 140803—Association between cardiorespiratory fitness and overall survival in operable lung cancer patients: Ancillary analysis of protocol 9238 No significant financial relationships to disclose ...

This trial was for people who had a pleural effusion caused by cancer. A pleural effusion is a build up of fluid in the space between the sheets of tissue that cover the outside of the lung and the ...

The excessive buildup of fluid in the space between your lungs and chest cavity, known as water fluid is also called Pleural effusion. The condition in which both the lungs get affected is called ...

UV1 plus ipilimumab (Yervoy) and nivolumab (Opdivo) produced a statistically significant and clinically meaningful survival improvement in patients with unresectable malignant pleural mesothelioma.